Stoke Therapeutics (STOK) Times Interest Earned (2025 - 2026)

Stoke Therapeutics' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$2322.5 for Q1 2026.

• In Q1 2026, Times Interest Earned fell 102.09% year-over-year to -$2322.5; the TTM figure through Mar 2026 stood at -$165.25 (down 436.62% YoY), while the FY2025 annual figure was -$0.11, up 97.75% from the prior year.
• Times Interest Earned for Q1 2026 stood at -$2322.5, down from -$56.16 in the prior quarter.
• The five-year high for Times Interest Earned was $111240.0 in Q1 2025, with the low at -$14363.7 in Q3 2025.
• The 5-year median for Times Interest Earned is -$26.96 (2022), against an average of $5440.8.
• The sharpest annual moves came in 2024 and 2025: Times Interest Earned tumbled 71336.33% in 2024, then soared 8725.69% in 2025.
• Stoke Therapeutics' Times Interest Earned stood at -$0.28 in 2022, then rose by 20.05% to -$0.22 in 2023, then slumped by 7858.15% to -$17.66 in 2024, then plunged by 217.96% to -$56.16 in 2025, then tumbled by 4035.55% to -$2322.5 in 2026.
• Business Quant data shows STOK's Times Interest Earned at -$2322.5 in Q1 2026, -$56.16 in Q4 2025, and -$14363.7 in Q3 2025.